pepinemab,ipilimumab,nivolumab,trastuzumab
bms,vaccinex,roche
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'pepinemab', 'vaccinex']
. w/ vaccinex presented the actively enrolling ph1/2 trial involving combination of pepinemab &amp; trastuzumab w/ adoptive transfer of dendritic cells followed by expanded autologous cd4+ t cells for patients w/ metastatic breast cancer at #sitc22 